Results 191 to 200 of about 3,066,509 (354)

Cyber-Physical Loops as Drivers of Value Creation in NDE 4.0. [PDF]

J Nondestr Eval, 2021
Vrana J, Singh R.
europepmc   +1 more source

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

Molecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti, Giovanni Germano, Pietro Paolo Vitiello, Alberto Bardelli   +3 more
wiley   +1 more source

KNOWLEDGE MANAGEMENT,COGNITIVE CARTOGRAPHY AND VALUE CREATION IN THE ORGANIZATION [PDF]

From the value of knowledge established in a disciplinary field by more specialists are moving to value theoretical knowledge in terms of utility that a company can hold in terms of a competitive advantage.
Nicolae Albu Ph. D, Prof. Mihai Vărzaru PhD.   +1 more
core  

Enzyme Catalysis for Sustainable Value Creation Using Renewable Biobased Resources. [PDF]

Molecules
Wohlgemuth R.
europepmc   +1 more source

An apple a day - how the platform economy impacts value creation in the healthcare market. [PDF]

Electron Mark, 2021
Gleiss A, Kohlhagen M, Pousttchi K.
europepmc   +1 more source

The Effect of Corporate Social Responsibility Dimensions on Value Creation of the Pharmaceutical and Non-Pharmaceutical Companies Listed on the Tehran Stock Exchange

, 2018
Leila Asadi, Ali Vaez, A. JerJer Zadeh, A. Kaab Amir   +3 more
openalex   +2 more sources

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

An Empirical Study of Value Creation Criteria: Case of Iran [PDF]

Today’s investors, creditors, and managers are look for an on-time and reliable index, with the goal of evaluating value creation amount. The aim of this study is inducing of voluble measures to users and increasing their understanding yielded these ...
Godratallah TALEBNYA, Hashem VALIPOUR, Mahdi SALEHI, Zahra YOUSEFI   +3 more
core  

Research on the Impact of Independent Innovation on Value Creation of Export-Oriented Chip Manufacturing Enterprises [PDF]

雨晴 周
openalex   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

Molecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken, Andrea Abel Gutierrez, Imke van Rossum, Cornelia G. Spruijt, Michiel Vermeulen, Guido van Mierlo, Blanca Scheijen, Annemiek B. van Spriel   +7 more
wiley   +1 more source